|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/473 | |
| A61K 31/44 | |||
| A01N 43/42 | |||
| A61K 47/02 | |||
| A61P 15/10 | |||
| A61P 25/16 |
| (11) | Number of the document | 2442650 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10786915.8 |
| Date of filing the European patent application | 2010-06-11 | |
| (97) | Date of publication of the European application | 2012-04-25 |
| (45) | Date of publication and mention of the grant of the patent | 2015-08-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/038336 |
| Date | 2010-06-11 |
| (87) | Number | WO 2010/144817 |
| Date | 2010-12-16 |
| (30) | Number | Date | Country code |
| 186445 P | 2009-06-12 | US |
| (72) |
GIOVINAZZO, Anthony, John, CA
HEDDEN, David, Bruce, US
DE SOMER, Marc, L., US
BRYSON, Nathan, John, CA
|
| (73) |
Cynapsus Therapeutics Inc.,
828 Richmond Street, W, Toronto, ON M6J 1C9,
CA
|
| (54) | SUBLINGUAL APOMORPHINE |
| SUBLINGUAL APOMORPHINE |